Postoperative Pain Control Following Vitreoretinal Surgery

Status Completed

Clinical Trial Summary

The aim of this study is to evaluate if patients receiving a steroid (triamcinolone acetonide) combined with local anesthesia and antibiotic following retina surgery have better postoperative pain control those receiving local anesthesia and antibiotic alone.

Clinical Trial Description

Currently, patients undergoing vitreoretinal surgery at the Emory Eye Center and Emory University Hospital receive a injection of local anesthesia behind the eye (retrobulbar) at the start of surgery to minimize discomfort felt during the surgery. At the end of surgery all patients receive a periocular antibiotic and steroid injection. Some patients also receive a retrobulbar injection of local anesthesia (bupivicaine) at the conclusion of surgery in order to decrease postoperative pain and discomfort.

It has been our observation that when the local anesthesia is combined with a steroid (triamcinolone acetonide) in a retrobulbar injection at the conclusion of surgery, patients tend to be pain free for longer intervals then when local anesthesia is used alone. The objective of this study is to evaluate if patients receiving triamcinolone acetonide combined with local anesthesia and antibiotic compared to those receiving local anesthesia and antibiotic alone do better with postoperative pain control.

All eligible patients undergoing vitreoretinal surgery at the Emory Eye Center and Emory University Hospital will be offered enrollment. About 60 patients will be invited to participate in this study. Patients will undergo standard of care surgery. At the conclusion of surgery, patients will receive a retrobulbar antibiotic and anesthetic as standard of care. Half of the patients will receive this mixture plus steroid and the other half will receive this mixture plus saline. On postoperative day 1, patients will be given a questionnaire to assess pain. Pain levels in the two groups will be compared. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01995045
Study type	Interventional
Source	Emory University
Contact
Status	Completed
Phase	Phase 4
Start date	July 2012
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03332758` - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Completed	`NCT03660384` - Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy	N/A
Recruiting	`NCT03713268` - Intraoperative OCT Guidance of Intraocular Surgery II
Completed	`NCT04535622` - Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery	N/A
Recruiting	`NCT05863312` - REtinal Detachment Outcomes Study	N/A
Recruiting	`NCT05561569` - Air Versus Gas Tamponade in Primary Retinal Detachment	N/A
Not yet recruiting	`NCT05538156` - Internal Limiting Membrane Peeling in Retinal Detachment Surgery	N/A
Completed	`NCT03046719` - Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal	N/A
Recruiting	`NCT01261533` - Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment	Phase 1
Terminated	`NCT02068625` - Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment	Phase 4
Completed	`NCT00000140` - The Silicone Study	Phase 3
Recruiting	`NCT05543018` - Effect of Intraocular Tamponade on Visual Perception	N/A
Not yet recruiting	`NCT04518696` - Suprachoroidal Buckling for the Management of Rhegmatogenous Retinal Detachment	N/A
Completed	`NCT03321253` - Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification	N/A
Completed	`NCT06166914` - Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment	N/A
Enrolling by invitation	`NCT05566626` - Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera	N/A
Not yet recruiting	`NCT03631108` - Feasibility Study and Preliminary Application Study on Iris OCTA
Recruiting	`NCT02201706` - Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye	N/A
Completed	`NCT03218371` - Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment.	N/A
Completed	`NCT00000154` - Diabetic Retinopathy Vitrectomy Study (DRVS)	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.